Navigation Links
CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting

BRANFORD, Conn., April 12, 2007 /PRNewswire-FirstCall/ -- CuraGen Corporation announced today that new preclinical data on belinostat (PXD101), a histone deacetylase (HDAC) inhibitor being investigated for the treatment of cancer, and velafermin, a protein being investigated for the prevention of severe oral mucositis, will be presented at the upcoming American Association for Cancer Research (AACR) 2007 Annual Meeting in Los Angeles, CA, April 14-18, 2007. A total of five poster presentations on belinostat (PXD101) and one poster presentation on velafermin will be made during the conference.

    Belinostat (PXD101), HDAC inhibitor for the treatment of cancer:


    -- "Activity of PXD101, an HDAC inhibitor, used alone or in combination

        with 5-FU in preclinical gastroesophageal studies," (Abstract #691)

        during the conference's HDAC Inhibitors I poster session on Sunday,

        April 15th in the Exhibit Hall, Poster Section 28 on Poster Board #14


    -- "Gene expression screen in cell panel selected for varying sensitivity

        towards the Histone Deacetylase inhibitor (HDACi) PXD101 reveals

        potential predictors of HDACi sensitivity," (Abstract #687) during the

        conference's HDAC Inhibitors I poster session on Sunday, April 15th in

        the Exhibit Hall, Poster Section 28 on Poster Board #10


    -- "The effect of the histone deacetylase inhibitor (HDACi) PXD101 on cell

        growth and expression of viral and host genes in hepatitis B virus

        (HBV)-carrying hepatocellular carcinoma (HCC) cell lines," (Abstract

        #696) during the conference's HDAC Inhibitors I poster session on

        Sunday, April 15th in the Exhibit Hall, Poster Section 28 on Poster

        Board #19


    -- "The histone deacetylase (HDAC) inhibitor PXD101 suppresses bladder

        cancer cell growth both in-vitro and in-vivo," (Abstract #2211) during

        the conference's Mouse Models of Cancer 2: Therapeutic A
'"/>




Page: 1 2 3 4 

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for
Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With
Belinostat to be Reported at Upcoming Major Medical Meetings
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on
GlycoPEGylated Factor VIIa at the XXI Congress of the International
Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy
of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in
Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird
Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II
Study of its Factor Xa Inhibitor at the XXI Congress of the
International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for
Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient
Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of
Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:5/24/2013)... , May 24, 2013 ... administration for systemic delivery of therapeutic agents has been ... inhalation drug delivery showing significant promise. The crucial formulation ... a delivery device play a major role in the ... made in the development of new formulation techniques and ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
(Date:5/24/2013)... May 24, 2013 This week is ... and their efforts to provide the best emergency care ... of this week is also to educate the public ... of survival. Citizens are the first link, and a ... proper bystander CPR after a cardiac arrest can triple ...
(Date:5/24/2013)... Bethany Beach, Delaware (PRWEB) May 24, 2013 ... Tammy Mushrush has joined the Dayna Feher team at ... Pa., Mushrush made the Delaware resorts her home in ... she has since worked in all aspects of the ... operations, and for the past 12 years, a licensed ...
(Date:5/24/2013)... 24, 2013 E-Dentists.com has announced the ... with JD Media Surge, a leading medical Internet marketing ... SEO analysis service will focus on providing dentists the ... engines for their competitive keywords. The dental SEO analysis ... recommendations based on what their competitors are doing right. ...
(Date:5/24/2013)... Let’s face it: very few are luckily ... the majority of people to be uncomfortable with the color ... coffee addiction or simply genetics, yellowish or stained teeth suppresses ... , Herald Square Dental is proud to announce ... Venus White Max. , Teeth become discolored for a ...
(Date:5/24/2013)... May 24, 2013 Mr. Brian Su, ... 3rd Annual EB-5 Investment Summit: Dealmakers Conference in Long ... will focus on exploring alternative finance through EB-5 immigrant ... legal and economic information, and updates to project developers, ... EB-5 industry. , "Our goal is to assist ...
Breaking Medicine News(10 mins):Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2
... ... ... contributions of voluntary plasma donors and the issue of treating critically ill ... proclaimed August "Plasma Protein Therapies Month" in the Lone Star State. , , ,"Patients ...
... ... on top of current events in the health care industry. , ... Seattle, Washington (PRWEB) August 19, 2009 -- Today, All Allied Health Schools ... helps students keep up with the latest developments in the health care industry--and how these changes ...
... , ANN ARBOR, Mich., Aug. 19 The median profit ... of 2008 to 3.1 percent in the first quarter of 2009, according ... , The recovery has been broad-based, with all classes ... major teaching hospitals -- showing positive median margins. , ...
... ... the Causes of this Growing Trend , ... Jacksonville, Fla. (Vocus) August 18, 2009 -- A recent National Institute of Health ... the growing popularity of alternative therapies for both healthcare treatment and prevention. ...
... A nearly two-decade trend that is stripping away employer-provided ... continue and could soon hit an even deeper pool ... Illinois elder law expert warns. Richard L. Kaplan ... largely from a 1992 change in accounting standards that ...
... , NEW YORK, NY, Aug. 18 /PRNewswire-FirstCall/ - (OTCBB: ... that identifies, acquires, and develops novel drug targets that ... Whiteman as its Chief Executive Officer. , Mr. Whiteman, ... London School of Economics . He will provide ...
Cached Medicine News:Health News:Plasma protein Therapies Association Focuses Attention on Donors and Facilities 2Health News:Plasma protein Therapies Association Focuses Attention on Donors and Facilities 3Health News:All Allied Health Schools Launches "Health Care Community" 2Health News:All Allied Health Schools Launches "Health Care Community" 3Health News:Thomson Reuters Study Finds Impact of Recession Easing on U.S. Hospitals 2Health News:Thomson Reuters Study Finds Impact of Recession Easing on U.S. Hospitals 3Health News:Alternative Therapies And Their Growing Popularity 2Health News:Alternative Therapies And Their Growing Popularity 3Health News:Alternative Therapies And Their Growing Popularity 4Health News:Retirees' health-care benefits at risk, study warns 2Health News:Retirees' health-care benefits at risk, study warns 3Health News:GENova names Aaron Whiteman as CEO 2Health News:GENova names Aaron Whiteman as CEO 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: